GlassScriptPhysician profile
Pawanjit S Sarna
NPI 1457379422
$18,968.95
in general payments reported to CMS, 2019-2025
40 companies · $1,961 in 2025
The $1,961 reported for 2025 was more than what 75% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $247 · 2021: $705 · 2022: $2,258 · 2023: $12K · 2024: $1,005 · 2025: $1,961.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,040 · Food and Beverage: $5,250 · Travel and Lodging: $1,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,039.90 |
| Food and Beverage | $5,249.92 |
| Travel and Lodging | $1,054.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,165.15 | 2021-2023 | Da Vinci Surgical System, Ion |
| Glaxosmithkline, LLC. | $1,821.13 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,679.17 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Mallinckrodt Hospital Products INC. | $629.80 | 2020-2023 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $621.70 | 2019-2023 | Ofev |
| Regeneron Healthcare Solutions, INC. | $487.39 | 2019-2025 | Dupixent |
| Insmed, INC. | $405.30 | 2019-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $311.83 | 2019-2024 | Yupelri |
| Genzyme Corporation | $293.93 | 2021-2024 | |
| Grifols USA, LLC | $289.84 | 2021-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $274.06 | 2021-2024 | Glassia |
| Philips North America LLC | $169.58 | 2020-2025 | Vest Therapy Und, Incourage Airway Clearance Therapy, (Ak6) Vest Therapy |
| Amgen INC. | $164.67 | 2022-2025 | Tezspire |
| Bayer Healthcare Pharmaceuticals INC. | $159.94 | 2019-2025 | |
| Ani Pharmaceuticals, INC. | $148.20 | 2023-2024 | Purified Cortrophin Gel |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $125.06 | 2020-2022 | |
| Actelion Pharmaceuticals US, INC. | $121.65 | 2021-2024 | Uptravi, Opsumit |
| Verona Pharma, INC. | $109.57 | 2025 | Ohtuvayre |
| Sanofi-Aventis U.S. LLC | $96.50 | 2022 | |
| Vifor Pharma, INC. | $88.32 | 2024-2025 | Zemaira, Veltassa |
| Viatris Specialty LLC | $79.40 | 2025 | Yupelri |
| Baxter Healthcare | $75.78 | 2023 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Paratek Pharmaceuticals, INC. | $68.04 | 2022-2023 | Nuzyra |
| Merck Sharp & Dohme LLC | $66.50 | 2019-2021 | |
| Pharming Healthcare, INC. | $65.76 | 2022-2024 | Ruconest |
| Novartis Pharmaceuticals Corporation | $56.87 | 2021-2023 | |
| United Therapeutics Corporation | $48.93 | 2020-2024 | Tyvaso |
| Pulmonx Corporation | $46.59 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Inogen, INC. | $38.53 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Electromed, INC. | $36.16 | 2019-2022 | |
| Atricure, INC. | $34.16 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Teva Pharmaceuticals USA, INC. | $27.33 | 2020-2023 | Airduo Digihaler |
| Circassia INC. | $23.82 | 2019 | |
| Phadia US INC. | $22.03 | 2022 | |
| Sunovion Pharmaceuticals INC. | $20.38 | 2019 | |
| Tactile Systems Technology INC | $20.04 | 2023 | Flexitouch Plus, Entre Plus |
| Lilly USA, LLC | $19.46 | 2025 | Zepbound |
| Pfizer INC. | $19.23 | 2025 | |
| Axsome Therapeutics, INC. | $19.17 | 2024 | Sunosi |
| Nabriva Therapeutics, Plc | $17.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pawanjit Sarna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.